In vivo models of human immunity in human tumor-bearing mice are frequently used to study mechanisms of targeted immunotherapies, safety, and efficacy. In a recent webinar Jenny Rowe, PhD, Scientist ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL), a leading early-stage contract research organization (CRO), announced the North American launch of its ...
In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies.
WILMINGTON, Del., July 26, 2022 /PRNewswire/ -- In order to bring new cutting-edge research models to the market to accelerate the development of novel therapeutics for a host of unmet medical needs, ...
Charles River Laboratories is incorporating HemaCare’s human peripheral blood mononuclear cells (PBMCs) into its NCG mouse model, further complementing its services in immuno-oncology and infectious ...
Selecting an appropriate mouse model is one of the most important decisions a pre-clinical researcher can make. Which is best suited for immuno-oncology? Cancer research and drug discovery has changed ...
WILMINGTON, Del., July 26, 2022 /PRNewswire/ -- In order to bring new cutting-edge research models to the market to accelerate the development of novel therapeutics for a host of unmet medical needs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results